Celsa Spina

Celsa Spina spearheads initiatives to address the challenges posed by latent HIV reservoirs, serving as an Associate Adjunct Professor of Pathology at the University of California-San Francisco. Her pioneering research is centered on the utilization of protein biomarkers to detect latent and persistent HIV-infected cell reservoirs, aiming to achieve this without the need for induced reactivation. This innovative approach holds promise for advancing the understanding and eventual eradication of HIV. As the Principal Investigator on numerous NIH-funded projects, Dr. Spina has made significant strides in targeting latently infected cells, a critical step towards HIV eradication. Her research delves into the complexities of controlling latent and persistent HIV infection, particularly within primary CD4 T cells, which are pivotal in the immune response. Her work is not only groundbreaking but also essential in the global fight against HIV/AIDS. Dr. Spina's research extends to the exploration of global gene regulation in CD4 T cell signaling, providing insights into the intricate mechanisms of immune response and HIV latency. Her contributions to the field are well-documented through her numerous publications, which cover a range of topics including HIV latency, gene regulation, and the immune responses associated with HIV infection. Through her dedication and expertise, Celsa Spina continues to push the boundaries of HIV research, offering hope for new therapeutic strategies and a deeper understanding of the virus's behavior within the human body. Her work not only advances scientific knowledge but also inspires future research endeavors aimed at combating one of the most challenging infectious diseases of our time.